11:18:58 EST Mon 16 Nov 2026
Enter Symbol
or Name
USA
CA



Jones Soda Co. - Common Shares
Symbol JSDA
Shares Issued 101,055,703
Close 2026-11-13 C$ 0.32
Market Cap C$ 32,337,825
Recent Sedar+ Documents

ORIGINAL: Jones Soda Co. Announces Completed Acquisition of UCAN Functional Nutrition Brand Assets Through Jones Labs

2026-11-16 07:30 ET - News Release

Jones Soda Co. Announces Completed Acquisition of UCAN Functional Nutrition Brand Assets Through Jones Labs

PR Newswire

Acquisition advances functional health and nutrition strategy; integration targets operational synergies and 2027 growth through Jones Club and retail channels

SEATTLE, Nov. 16, 2026 /PRNewswire/ -- Jones Soda Co. (CSE: JSDA) (OTCQB: JSDA) ("Jones Soda" or the "Company") today announced that, on November 12, 2026, its Jones Labs business acquired substantially all operating assets associated with the UCAN functional nutrition brand. The transaction included approximately $700,000 in cash consideration and approximately $500,000 in assumed liabilities.

The acquisition advances the Company's functional health and nutrition strategy discussed in connection with its third-quarter 2026 financial results. Jones Soda intends to integrate UCAN's products, brand, customer relationships and distribution channels into its existing systems, processes and personnel to maximize operational efficiencies and synergies.

Based on historical financial information provided by the seller, UCAN-related operations generated approximately $4.9 million of net revenue and $1.9 million of gross profit in the nine months ended September 30, 2026, representing a gross margin of approximately 40%. Full-year 2026 revenue for those operations was projected at approximately $6 million. These figures relate to UCAN operations before the acquisition and are not Jones Soda historical results or assurances of future performance.

UCAN Functional Nutrition Portfolio

UCAN is a metabolic performance nutrition brand focused on sustained energy, endurance and active lifestyles. Its portfolio includes energy gels, nutrition bars, drink mixes, hydration products and protein nutrition offerings marketed to athletes and active consumers. Certain products incorporate LIVSTEADY™ carbohydrate technology.

Strategic Rationale

Scott Harvey, Chief Executive Officer of Jones Soda, commented:

"The UCAN acquisition represents a tangible step forward in our functional health and nutrition strategy. We believe UCAN has significantly untapped growth potential by reaching consumers through new channels focused on metabolic health, performance nutrition and everyday wellness. Our priority is to identify and develop distribution opportunities that align with these consumer needs while leveraging Jones Soda's infrastructure, operational capabilities and resources to support scalable growth and meaningful operating efficiencies."

"We expect to grow the UCAN business in 2027, leveraging our commercial infrastructure and customer relationships. We also expect UCAN's direct-to-consumer activities to expand the scale of our existing DTC business, subject to successful integration."

Transaction Overview

The transaction closed November 12, 2026. In addition to approximately $700,000 of cash consideration, Jones Soda assumed approximately $500,000 of liabilities, including approximately $400,000 of existing licensing fees payable in January 2027 and approximately $100,000 of other liabilities. Of the January 2027 licensing obligation, approximately $200,000 is to be satisfied through issuance of Jones Soda common shares to Glycologic Limited, priced at the market price at the time of issuance.

About Jones Soda Co.

Jones Soda Co.® (CSE: JSDA, OTCQB: JSDA) markets and distributes premium craft sodas under the Jones® Soda brand across North America. The Company is headquartered in Seattle, Washington. For more information, visit www.jonessoda.com.

Forward-Looking Statements

Statements about expected 2027 UCAN growth, distribution expansion, Jones Club opportunities, integration, operating synergies and future results are forward-looking statements under applicable U.S. and Canadian securities laws. Actual results may differ materially due to risks including customer retention, product demand, licensing and intellectual-property rights, regulatory compliance, integration costs, retail performance, working-capital requirements and financing needs, as well as risks described in the Company's SEC filings, including its 2025 Form 10-K and September 30, 2026 Form 10-Q. Forward-looking statements speak only as of their date, and the Company undertakes no obligation to update them except as required by law.

View original content to download multimedia:https://www.prnewswire.com/news-releases/jones-soda-co-announces-completed-acquisition-of-ucan-functional-nutrition-brand-assets-through-jones-labs-302939876.html

SOURCE Jones Soda Co.

Contact:

Investor Relations Contact: James Carbonara, Hayden IR | james@haydenir.com | (646) 755-7412

© 2026 Canjex Publishing Ltd. All rights reserved.